{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:25:43Z","timestamp":1787574343138,"version":"build-2736575974"},"reference-count":134,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274146"],"award-info":[{"award-number":["82274146"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["82274146"],"award-info":[{"award-number":["82274146"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>As the core transcriptional co-activators of the Hippo signaling pathway, YAP and TAZ play essential roles in maintaining tissue homeostasis and in tumorigenesis. Their aberrant activation is frequently observed in human malignancies, and accumulating evidence has identified them as crucial drivers of tumor initiation and progression. YAP\/TAZ have been recently recognized as key regulators of cellular metabolic reprogramming, a hallmark of cancer that fuels tumor cell proliferation by rewiring glucose, lipid, amino acid, and nucleotide metabolism. Conversely, the activity of YAP\/TAZ is modulated by metabolites such as glucose and lipids, establishing a complex bidirectional regulatory circuit. Therefore, deciphering this intricate crosstalk is of great importance for cancer therapy and drug discovery. In this review, we systematically clarify the interplay between YAP\/TAZ and metabolic reprogramming in cancer, delineate the core molecular networks through which YAP\/TAZ govern each metabolic pathway, and summarize the current pharmacological inhibitors targeting YAP\/TAZ-regulated metabolic networks. Collectively, these findings pave the way for therapeutic approaches targeting YAP\/TAZ-driven metabolic vulnerabilities in cancer.<\/jats:p>","DOI":"10.3390\/ijms27177537","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:47:19Z","timestamp":1787572039000},"page":"7537","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Crosstalk Between YAP\/TAZ and Cancer Metabolism: From Mechanistic Insights to Drug Discovery"],"prefix":"10.3390","volume":"27","author":[{"given":"Yinhuang","family":"Gao","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8604-1279","authenticated-orcid":false,"given":"Minghong","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songxia","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China"},{"name":"Institute of Clinical Pharmacology, Sun Yat-sen University, Guangzhou 510006, China"},{"name":"Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China"},{"name":"Institute of Clinical Pharmacology, Sun Yat-sen University, Guangzhou 510006, China"},{"name":"Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,23]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12943-018-0882-1","article-title":"The role of YAP\/TAZ activity in cancer metabolic reprogramming","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yexcr.2017.10.006","article-title":"Biomechanical strain-induced modulation of proliferation coincides with an ERK1\/2-independent nuclear YAP localization","volume":"361","author":"Wein","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ncb2936","article-title":"Metabolic control of YAP and TAZ by the mevalonate pathway","volume":"16","author":"Sorrentino","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17368","DOI":"10.1073\/pnas.1308236110","article-title":"Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1\/2 protein kinases","volume":"110","author":"Adler","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","article-title":"YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells","volume":"17","author":"Camargo","year":"2007","journal-title":"Curr. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","article-title":"Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals","volume":"130","author":"Dong","year":"2007","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10555-013-9463-3","article-title":"The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy","volume":"33","author":"Wang","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10137","article-title":"Role of YAP\/TAZ in mechanotransduction","volume":"474","author":"Dupont","year":"2011","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","article-title":"Interplay between YAP\/TAZ and Metabolism","volume":"28","author":"Koo","year":"2018","journal-title":"Cell Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","article-title":"YAP\/TAZ upstream signals and downstream responses","volume":"20","author":"Totaro","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the Roots of Cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Holden, J.K., and Cunningham, C.N. (2018). Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors. Cancers, 10.","DOI":"10.3390\/cancers10030081"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrc3876","article-title":"The emerging roles of YAP and TAZ in cancer","volume":"15","author":"Moroishi","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.devcel.2019.07.022","article-title":"A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas","volume":"51","author":"Murakami","year":"2019","journal-title":"Dev. Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.15252\/embj.201797609","article-title":"LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism","volume":"36","author":"Zheng","year":"2017","journal-title":"EMBO J."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Fujita, M., Orisaka, M., Mizutani, T., Fujita, Y., Onuma, T., Tsuyoshi, H., and Yoshida, Y. (2025). YAP\/TAZ Promote GLUT1 Expression and Are Associated with Prognosis in Endometrial Cancer. Cancers, 17.","DOI":"10.3390\/cancers17152554"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41416-022-02106-9","article-title":"Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP\/TAZ-Hedgehog signalling axis in pancreatic cancer","volume":"128","author":"Liu","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e30613","DOI":"10.1002\/jcb.30613","article-title":"AKT1 Promotes Tumorigenesis and Metastasis by Directly Phosphorylating Hexokinases","volume":"125","author":"Yu","year":"2024","journal-title":"J. Cell. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbrc.2020.06.105","article-title":"Hippo pathway cooperates with ChREBP to regulate hepatic glucose utilization","volume":"530","author":"Shu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2266732","DOI":"10.1080\/08941939.2023.2266732","article-title":"Verteporfin Suppresses YAP-Induced Glycolysis in Breast Cancer Cells","volume":"36","author":"Chen","year":"2023","journal-title":"J. Investig. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"143956","DOI":"10.1016\/j.gene.2019.143956","article-title":"Oleanolic acid reduces aerobic glycolysis-associated proliferation by inhibiting yes-associated protein in gastric cancer cells","volume":"712","author":"Li","year":"2019","journal-title":"Gene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cellsig.2019.03.011","article-title":"AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-\u03baB, HIF1\u03b1, MMP2, and MMP9 upregulation","volume":"58","author":"Li","year":"2019","journal-title":"Cell. Signal."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41467-022-28440-3","article-title":"A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis","volume":"13","author":"Blaha","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41389-019-0143-1","article-title":"Phosphorylation of 14-3-3\u03b6 links YAP transcriptional activation to hypoxic glycolysis for tumorigenesis","volume":"8","author":"Jia","year":"2019","journal-title":"Oncogenesis"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chen, Y., Guo, Y., Yuan, M., Guo, S., Cui, S., and Chen, D. (2023). USP4 promotes the proliferation and glucose metabolism of gastric cancer cells by upregulating PKM2. PLoS ONE, 18.","DOI":"10.21203\/rs.3.rs-3002675\/v1"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41419-021-04124-6","article-title":"Notch1\/TAZ axis promotes aerobic glycolysis and immune escape in lung cancer","volume":"12","author":"Xie","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/s42003-024-06993-x","article-title":"FUT2 promotes colorectal cancer metastasis by reprogramming fatty acid metabolism via YAP\/TAZ signaling and SREBP-1","volume":"7","author":"Dong","year":"2024","journal-title":"Commun. Biol."},{"key":"ref_30","first-page":"606","article-title":"ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1\/YAP axis","volume":"21","author":"Tan","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1111\/jcmm.14262","article-title":"A functional interaction between Hippo-YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice","volume":"23","author":"Shu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.devcel.2022.02.004","article-title":"YAP regulates an SGK1\/mTORC1\/SREBP-dependent lipogenic program to support proliferation and tissue growth","volume":"57","author":"Vaidyanathan","year":"2022","journal-title":"Dev. Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.aav0173","article-title":"Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation","volume":"363","author":"Lee","year":"2019","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.molcel.2021.04.009","article-title":"The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability","volume":"81","author":"Pan","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Huang, H., Chen, J., Zhong, P., Peng, S., Zhong, Q., Deng, C., Wang, F., Lu, Z., Liu, Y., and Chen, L. (2026). KLF5-driven TAZ-FASN signaling reprograms fatty acid metabolism to support Treg differentiation in lung cancer. J. Transl. Med., in press.","DOI":"10.1186\/s12967-026-08557-5"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"eabm8786","DOI":"10.1126\/sciadv.abm8786","article-title":"Suppression of nuclear GSK3 signaling promotes serine\/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells","volume":"8","author":"He","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ncb3389","article-title":"Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth","volume":"18","author":"Cox","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41467-024-55769-8","article-title":"Positive feedback between arginine methylation of YAP and methionine transporter SLC43A2 drives anticancer drug resistance","volume":"16","author":"Hong","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e70558","DOI":"10.1096\/fj.202401788RR","article-title":"Epigenetic Activation of PTCD3 Promotes CRC Glutamine Metabolism and Metastasis via IGF2BP2-Mediated SLC38A2 m6A Modification","volume":"39","author":"Peng","year":"2025","journal-title":"FASEB J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/hep.28223","article-title":"Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma","volume":"63","author":"Park","year":"2015","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.7150\/ijbs.48066","article-title":"NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence via the induction of ASCT2","volume":"16","author":"Ding","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e43577","DOI":"10.15252\/embr.201643577","article-title":"Glutamine-utilizing transaminases are a metabolic vulnerability of TAZ\/YAP-activated cancer cells","volume":"19","author":"Yang","year":"2018","journal-title":"EMBO Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"BSR20171072","DOI":"10.1042\/BSR20171072","article-title":"YAP\/TAZ-mediated activation of serine metabolism and methylation regulation is critical for LKB1-deficient breast cancer progression","volume":"37","author":"Wu","year":"2017","journal-title":"Biosci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhao, X., Fu, J., Hu, B., Chen, L., Wang, J., Fang, J., Ge, C., Lin, H., Pan, K., and Fu, L. (2021). Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.639111"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"115006","DOI":"10.1016\/j.biopha.2023.115006","article-title":"YY2\/PHGDH axis suppresses tumorigenesis by inhibiting tumor cell de novo serine biosynthesis","volume":"165","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41556-022-00848-5","article-title":"YAP\/TAZ drives cell proliferation and tumour growth via a polyamine\u2013eIF5A hypusination\u2013LSD1 axis","volume":"24","author":"Li","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/cr.2015.140","article-title":"The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1","volume":"25","author":"Hansen","year":"2015","journal-title":"Cell Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1878-0261.12999","article-title":"Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1","volume":"15","author":"Kandasamy","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"216756","DOI":"10.1016\/j.canlet.2024.216756","article-title":"APIP regulated by YAP propels methionine cycle and metastasis in head and neck squamous cell carcinoma","volume":"588","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13045-024-01655-1","article-title":"D-ribose-5-phosphate inactivates YAP and functions as a metabolic checkpoint","volume":"18","author":"Tu","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e100294","DOI":"10.15252\/embj.2018100294","article-title":"Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth","volume":"37","author":"Cox","year":"2018","journal-title":"EMBO J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s10528-025-11070-x","article-title":"Integrative Phosphoproteomic and Metabolomic Analysis of Disruption of Metabolic Homeostasis in Breast Cancer: A Pilot Study","volume":"64","author":"Niu","year":"2025","journal-title":"Biochem. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Yuan, J.-q., Ding, N.-h., and Xiao, Z. (2020). The Hippo Transducer YAP\/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.537265"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/s44321-025-00278-4","article-title":"De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma","volume":"17","author":"Xu","year":"2025","journal-title":"EMBO Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e97780","DOI":"10.15252\/embj.201797780","article-title":"dNTP metabolism links mechanical cues and YAP\/TAZ to cell growth and oncogene-induced senescence","volume":"37","author":"Santinon","year":"2018","journal-title":"EMBO J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1038\/s41598-022-07600-x","article-title":"Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased \u03b22 adrenergic agonist","volume":"12","author":"Wnorowski","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.tcb.2023.03.003","article-title":"Regulation of nucleotide metabolism in cancers and immune disorders","volume":"33","author":"Ali","year":"2023","journal-title":"Trends Cell Biol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Ferraiuolo, M., Verduci, L., Blandino, G., and Strano, S. (2017). Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050961"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1038\/s41388-018-0153-z","article-title":"How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations","volume":"37","author":"Rehrauer","year":"2018","journal-title":"Oncogene"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1159\/000485946","article-title":"YAP Inhibits the Apoptosis and Migration of Human Rectal Cancer Cells via Suppression of JNK-Drp1-Mitochondrial Fission-HtrA2\/Omi Pathways","volume":"44","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.devcel.2019.04.014","article-title":"YAP\/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells","volume":"49","author":"White","year":"2019","journal-title":"Dev. Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"101885","DOI":"10.1016\/j.mito.2024.101885","article-title":"The interplay between hippo signaling and mitochondrial metabolism: Implications for cellular homeostasis and disease","volume":"76","author":"Biswal","year":"2024","journal-title":"Mitochondrion"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1158\/2767-9764.CRC-22-0142","article-title":"Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis","volume":"2","author":"Greer","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Hsu, S.-C., Lin, C.-Y., Lin, Y.-Y., Collins, C.C., Chen, C.-L., and Kung, H.-J. (2022). TEAD4 as an Oncogene and a Mitochondrial Modulator. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.890419"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Yun, U.-J., Bae, S.-J., Song, Y.-R., and Kim, Y.-W. (2022). A Critical YAP in Malignancy of HCC Is Regulated by Evodiamine. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031855"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"156287","DOI":"10.1016\/j.phymed.2024.156287","article-title":"Cyclovirobuxine D inhibits triple-negative breast cancer via YAP\/TAZ suppression and activation of the FOXO3a\/PINK1-Parkin pathway-induced mitophagy","volume":"136","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"He, Z., Shi, J., Zhu, B., Tian, Z., and Zhang, Z. (2024). Transcriptomics analysis revealed that TAZ regulates the proliferation of KIRC cells through mitophagy. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-11903-9"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.15252\/embj.201490379","article-title":"Aerobic glycolysis tunes YAP\/TAZ transcriptional activity","volume":"34","author":"Enzo","year":"2015","journal-title":"EMBO J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/1878-0261.12438","article-title":"Molecular evidence of field cancerization initiated by diabetes in colon cancer patients","volume":"13","author":"Minguez","year":"2019","journal-title":"Mol. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.7150\/thno.32915","article-title":"Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit","volume":"9","author":"Kuo","year":"2019","journal-title":"Theranostics"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.7150\/ijbs.69526","article-title":"Enhanced pentose phosphate pathway activity promotes pancreatic ductal adenocarcinoma progression via activating YAP\/MMP1 axis under chronic acidosis","volume":"18","author":"Chen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41420-022-00842-8","article-title":"YAP ISGylation increases its stability and promotes its positive regulation on PPP by stimulating 6PGL transcription","volume":"8","author":"Xue","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41419-023-05919-5","article-title":"Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity","volume":"14","author":"Yan","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00204-023-03495-3","article-title":"Exposure to dietary fatty acids oleic and palmitic acid alters structure and mechanotransduction of intestinal cells in vitro","volume":"97","author":"Bergen","year":"2023","journal-title":"Arch. Toxicol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e2306827","DOI":"10.1002\/advs.202306827","article-title":"CSN6-SPOP-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"217528","DOI":"10.1016\/j.canlet.2025.217528","article-title":"SQLE amplification accelerates esophageal squamous cell carcinoma tumorigenesis and metastasis through oncometabolite 2,3-oxidosqualene repressing Hippo pathway","volume":"621","author":"Liu","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40164-024-00558-8","article-title":"Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment","volume":"13","author":"Wang","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13062-025-00655-6","article-title":"LDHA-mediated YAP lactylation promotes the tumor progression of hepatocellular carcinoma by inducing YAP dephosphorylation and activation","volume":"20","author":"Wei","year":"2025","journal-title":"Biol. Direct"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Dong, X., Zhang, X., Liu, P., Tian, Y., Li, L., and Gong, P. (2022). Lipolysis-Stimulated Lipoprotein Receptor Impairs Hepatocellular Carcinoma and Inhibits the Oncogenic Activity of YAP1 via PPPY Motif. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.896412"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1038\/s41467-025-62566-4","article-title":"Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth","volume":"16","author":"Zhao","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1038\/s41388-023-02811-6","article-title":"YAP governs cellular adaptation to perturbation of glutamine metabolism by regulating ATF4-mediated stress response","volume":"42","author":"Kim","year":"2023","journal-title":"Oncogene"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1158\/1078-0432.CCR-15-0226","article-title":"Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression","volume":"2","author":"Lee","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41467-018-07987-0","article-title":"Dickkopf-3 links HSF1 and YAP\/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts","volume":"10","author":"Ferrari","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yexcr.2018.07.041","article-title":"Paracrine HGF\/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP\/HIF-1\u03b1","volume":"371","author":"Yan","year":"2018","journal-title":"Exp. Cell Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cmet.2018.09.012","article-title":"Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy","volume":"29","author":"Bertero","year":"2019","journal-title":"Cell Metab."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Noguchi, S., Saito, A., and Nagase, T. (2018). YAP\/TAZ Signaling as a Molecular Link between Fibrosis and Cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113674"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Liu, Q.-P., Luo, Q., Deng, B., Ju, Y., and Song, G.-B. (2020). Stiffer Matrix Accelerates Migration of Hepatocellular Carcinoma Cells through Enhanced Aerobic Glycolysis Via the MAPK-YAP Signaling. Cancers, 12.","DOI":"10.3390\/cancers12020490"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13046-020-01689-6","article-title":"A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma","volume":"39","author":"Ben","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"216792","DOI":"10.1016\/j.canlet.2024.216792","article-title":"Hypoxia effects on glioblastoma progression through YAP\/TAZ pathway regulation","volume":"588","author":"Castillo","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"113389","DOI":"10.1016\/j.yexcr.2022.113389","article-title":"HIF-2\u03b1-induced upregulation of CD36 promotes the development of ccRCC","volume":"421","author":"Liao","year":"2022","journal-title":"Exp. Cell Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.2147\/OTT.S109979","article-title":"Verteporfin, a suppressor of YAP\u2013TEAD complex, presents promising antitumor properties on ovarian cancer","volume":"9","author":"Li","year":"2016","journal-title":"OncoTargets Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"118330","DOI":"10.1016\/j.ejmech.2025.118330","article-title":"Targeting YAP\/TAZ-TEAD and their protein-protein interaction for precision cancer therapy","volume":"302","author":"Chen","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.str.2015.09.009","article-title":"Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy","volume":"23","author":"Pobbati","year":"2015","journal-title":"Structure"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/1535-7163.MCT-20-0717","article-title":"Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma","volume":"20","author":"Tang","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"ref_95","first-page":"4399","article-title":"The novel potent TEAD inhibitor, K-975, inhibits YAP1\/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma","volume":"10","author":"Kaneda","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"111738","DOI":"10.1016\/j.cellsig.2025.111738","article-title":"A YAP-derived peptide blocks YAP-TEAD signaling and suppresses cell proliferation","volume":"131","author":"Yuan","year":"2025","journal-title":"Cell. Signal."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1096\/fj.14-262980","article-title":"Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides","volume":"29","author":"Zhou","year":"2015","journal-title":"FASEB J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e03277","DOI":"10.1002\/advs.202503277","article-title":"Discovery of a Potent and Selective TEAD Degrader with Durable Degradation Activity","volume":"12","author":"Cao","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"15168","DOI":"10.1021\/acs.jmedchem.4c00815","article-title":"Exploring Degradation of Intrinsically Disordered Protein Yes-Associated Protein Induced by Proteolysis TArgeting Chimeras","volume":"67","author":"Zhou","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Battina, R., Rahhal, R., Wellstein, A., Riegel, A.T., and Sharif, G.M. (2025). Targeting TEAD in cancer. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1692512"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/s12276-025-01551-9","article-title":"The multifaceted role of YAP in the tumor microenvironment and its therapeutic implications in cancer","volume":"57","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Cancer Discovery Editorial Board (2026). First-in-class YAP\/TEAD Inhibitor Shows Promise in Hippo-driven Mesothelioma. Cancer Discov., 16, OF1.","DOI":"10.1158\/2159-8290.CD-RW2025-107"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1038\/s41591-025-04029-3","article-title":"YAP\/TEAD inhibitor VT3989 in solid tumors: A phase 1\/2 trial","volume":"31","author":"Yap","year":"2025","journal-title":"Nat. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"S562","DOI":"10.1016\/j.annonc.2025.08.1489","article-title":"920O Safety and efficacy of first-in-class, YAP\/TEAD inhibitor, VT3989 in refractory pleural and non-pleural mesothelioma: A Phase I\/II study","volume":"36","author":"Yap","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"S562","DOI":"10.1016\/j.annonc.2025.08.1488","article-title":"919O A first-in-human study of oral IAG933 in adult patients with advanced mesothelioma and other solid tumours","volume":"36","author":"Garralda","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s43018-024-00754-9","article-title":"Direct and selective pharmacological disruption of the YAP\u2013TEAD interface by IAG933 inhibits Hippo-dependent and RAS\u2013MAPK-altered cancers","volume":"5","author":"Chapeau","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1158\/1538-7445.AM2024-1656","article-title":"Abstract 1656: ISM6331, a novel and potent pan-TEAD inhibitor, exhibits strong anti-tumor activity in preclinical models of Hippo pathway-dysregulated cancers","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"B13","DOI":"10.1158\/1557-3125.HIPPO19-B13","article-title":"Abstract B13: Cancer metabolism sensitizes metformin treatment by targeting the Hippo-YAP\/TAZ pathway","volume":"18","author":"Park","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"ref_109","first-page":"996","article-title":"YAP\/TAZ regulates the insulin signaling via IRS1\/2 in endometrial cancer","volume":"6","author":"Wang","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"177002","DOI":"10.1016\/j.ejphar.2024.177002","article-title":"Dapagliflozin suppressed gastric cancer growth via regulating OTUD5 mediated YAP1 deubiquitination","volume":"983","author":"Ren","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.celrep.2014.09.036","article-title":"Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein","volume":"9","author":"DeRan","year":"2014","journal-title":"Cell Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1158\/1535-7163.MCT-17-0560","article-title":"A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma","volume":"17","author":"Song","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.chembiol.2018.11.010","article-title":"Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD\u22c5Yap Protein-Protein Interaction","volume":"26","author":"Zhou","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.trecan.2023.07.016","article-title":"Targeting TEAD-ious resistance","volume":"9","author":"Ott","year":"2023","journal-title":"Trends Cancer"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1021\/acsmedchemlett.3c00386","article-title":"Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration","volume":"14","author":"Fnaiche","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1038\/s41467-022-34559-0","article-title":"Pharmacological blockade of TEAD\u2013YAP reveals its therapeutic limitation in cancer cells","volume":"13","author":"Sun","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccell.2019.12.006","article-title":"Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway","volume":"37","author":"Kurppa","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.4049\/jimmunol.2200568","article-title":"Lipophilic Statins Inhibit YAP Nuclear Localization, Coactivator Activity, and Migration in Response to Ligation of HLA Class I Molecules in Endothelial Cells: Role of YAP Multisite Phosphorylation","volume":"210","author":"Anwar","year":"2023","journal-title":"J. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e2400809121","DOI":"10.1073\/pnas.2400809121","article-title":"Hapalindole Q suppresses autophagosome-lysosome fusion by promoting YAP1 degradation via chaperon-mediated autophagy","volume":"121","author":"Wu","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/cas.70317","article-title":"Resveratrol as a Novel YAP Inhibitor Targeting Glioblastoma Progression and Sensitizing to Chemotherapy","volume":"117","author":"Khotchawan","year":"2026","journal-title":"Cancer Sci."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Jiang, Z., Chen, X., Chen, K., Sun, L., Gao, L., Zhou, C., Lei, M., Duan, W., Wang, Z., and Ma, Q. (2016). YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine. Nutrients, 8.","DOI":"10.3390\/nu8100546"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"16270","DOI":"10.1021\/acs.jmedchem.4c00925","article-title":"Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents","volume":"67","author":"Zhou","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"114116","DOI":"10.1016\/j.isci.2025.114116","article-title":"Alexidine is a TAZ-specific small-molecule inhibitor that suppresses breast cancer invasion and metastasis","volume":"28","author":"Ge","year":"2025","journal-title":"iScience"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1158\/1535-7163.MCT-23-0538","article-title":"Activation of Hepatocyte Growth Factor\/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1\/TEAD Small Molecule Inhibitor","volume":"23","author":"Moure","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2419925","DOI":"10.1080\/14756366.2024.2419925","article-title":"Exploring structural and biological insights of TEAD through rational design and synthesis of niflumic acid derivatives","volume":"39","author":"Choi","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-22-0681","article-title":"A novel irreversible TEAD inhibitor, SWTX-143, blocks Hippo pathway transcriptional output and causes tumor regression in preclinical mesothelioma models","volume":"23","author":"Hillen","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1039\/D5MD00928F","article-title":"CNS penetrant TEAD1,2,4 inhibitor MSC-4070 derived from phenotypic screening hit optimization","volume":"17","author":"Heinrich","year":"2026","journal-title":"RSC Med. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"118299","DOI":"10.1016\/j.ejmech.2025.118299","article-title":"Discovery of repurposed ethacrynic acid and its derivatives as novel TEAD inhibitors","volume":"302","author":"Chen","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7150\/jca.32436","article-title":"Anti-oral Squamous Cell Carcinoma Effects of a Potent TAZ Inhibitor AR-42","volume":"11","author":"Su","year":"2020","journal-title":"J. Cancer"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"129488","DOI":"10.1016\/j.bmcl.2023.129488","article-title":"Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings","volume":"95","author":"Fnaiche","year":"2023","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1039\/D3CB00044C","article-title":"A covalent inhibitor of the YAP-TEAD transcriptional complex identified by high-throughput screening","volume":"4","author":"Nutsch","year":"2023","journal-title":"RSC Chem. Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/ml500160m","article-title":"Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein Interaction","volume":"5","author":"Zhang","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ccr.2014.01.010","article-title":"A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer","volume":"25","author":"Jiao","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"9374","DOI":"10.1038\/s41467-025-64426-7","article-title":"Targeted degradation of endogenous YAP by nanobody bioPROTAC inhibits tumor progression","volume":"16","author":"Zhou","year":"2025","journal-title":"Nat. Commun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7537\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:54:21Z","timestamp":1787572461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,23]]},"references-count":134,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177537"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177537","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,23]]}}}